Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Perry who wrote (377)	6/22/1998 12:19:00 PM
From: Anthony Wong	Respond to of 1722

Pfizer Gets Swiss Approval to Sell Impotence Drug Viagra Bloomberg News June 22, 1998, 5:31 a.m. PT Pfizer Gets Swiss Approval to Sell Impotence Drug Viagra Bern, June 22 (Bloomberg) -- Pfizer Inc. got approval to sell its impotency treatment Viagra in Switzerland, the Swiss drug authority said. It's the product's first approval in Europe and the third altogether for the drug, which broke sales records when it was introduced in the U.S. More than 1 million Viagra prescriptions were written in the U.S. within a weeks of its launch in May, and Swiss pharmacies have already dispensed Viagra, even before the approval, on ''emergency'' prescriptions. It is also sold in Thailand. Viagra is popular because it's easier to use than the injections, penile insertions, and vacuum tubes previously available for treating impotence. An advisory panel to the European Medicines Evaluation Agency recently recommended that the drug be approved in the European Union, and full approval is expected in the next few months. Pfizer shares fell 2 7/8 to 111 1/2 in the U.S. Friday. Still, the shares have doubled in the past year on optimism about Viagra sales. The announcement by Swiss Control Office for Medication was made before the U.S. market opened. --Theresa Waldrop in the Zurich newsroom (41-1) 224 4111, with